Sulfuric Acid

Sulfuric Acid

SCHEMBL1552980

CCN.O=S(=O)([O-])O.[H+]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CYP51cyp51Acyp51c

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfuric Acid SCHEMBL10450188 0.88
Sulfuric Acid SCHEMBL11235635 0.86
Sulfuric Acid SCHEMBL3727155 0.82
Sulfuric Acid SCHEMBL921788 0.82
Sulfuric Acid SCHEMBL3677190 0.82 CA5A (0.50)
Sulfuric Acid SCHEMBL8766489 0.82 CA5A (0.50)
Thiosulfuric Acid SCHEMBL27524045 0.81
Butylamine SCHEMBL4171119 0.81 APP (0.44)
Butylamine SCHEMBL288210 0.81 APP (0.44)
Sulfuric Acid SCHEMBL6509471 0.79 CA5A (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11118308-B2 Treatment of lignocellulosic biomass with ionic liquid IP2IPO INNOVATIONS LIMITED (GB) 2021-09-14 US claimed
US-20180327969-A1 Treatment IMPERIAL INNOVATIONS LIMITED (GB) 2018-11-15 US claimed
US-20160040354-A1 Treatment IMPERIAL INNOVATIONS LIMITED (GB) 2016-02-11 US claimed
EP-2971333-A1 TREATMENT Imperial Innovations Ltd (GB) 2016-01-20 EP claimed
WO-2014140643-A1 TREATMENT IMPERIAL INNOVATIONS LIMITED (GB) 2014-09-18 WO claimed
JP-2195874-A None JP disclosed
US-20250347033-A1 METHOD FOR MAKING FIBRES IMPERIAL COLLEGE INNOVATIONS LTD (GB) 2025-11-13 US disclosed
US-20250283255-A1 METHOD FOR MAKING FIBRES IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2025-09-11 US disclosed
EP-4532807-A2 METHOD FOR MAKING FIBRES Imperial College Innovations Limited (GB) 2025-04-09 EP disclosed
EP-4532808-A1 METHOD FOR MAKING FIBRES Imperial College Innovations Limited (GB) 2025-04-09 EP disclosed
WO-2023232906-A1 METHOD FOR MAKING FIBRES IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2023-12-07 WO disclosed
WO-2023232905-A2 METHOD FOR MAKING FIBRES IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) 2023-12-07 WO disclosed
WO-2014140643-A1 TREATMENT IMPERIAL INNOVATIONS LIMITED (GB) 2014-09-18 WO disclosed
US-20140113882-A1 Azaquinazoline Inhibitors of Atypical Protein Kinase C CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2014-04-24 US disclosed
EP-1844026-B1 MORPHOLINES AS 5HT2C AGONISTS HOFFMANN LA ROCHE (CH) 2011-04-27 EP disclosed
US-7323466-B2 Morpholine derivatives as 5HT2C receptor agonists for the treatment of obesity HOFFMAN-LA ROCHE INC. (US) 2008-01-29 US disclosed
EP-1844026-A2 MORPHOLINES AS 5HT2C AGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2007-10-17 EP disclosed
US-20060178510-A1 New morpholine derivatives as 5HT2C receptor agonists for the treatment of obesity HOFFMANN-LA ROCHE INC. 2006-08-10 US disclosed
WO-2006077025-A2 MORPHOLINES AS 5HT2C AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2006-07-27 WO disclosed
JP-H02195874-A CULTURE MEDIUM FOR CULTURING ANIMAL TISSUE KOOJIN BIO KK 1990-08-02 JP disclosed